A snapshot of cancer vaccine development
The Koch Institute’s Annual Symposium highlights emerging successes and challenges in the advancement of vaccines to prevent and treat cancer.
Search Stories
Freeman Hrabowski encourages students to “hold fast to dreams” and take time for laughter
In a visit to MIT, the educator and author led a lively and inspiring Q&A with students.
Gene-editing technique could speed up study of cancer mutations
With the new method, scientists can explore many cancer mutations whose roles are unknown, helping them develop new drugs that target those mutations.
Nanoparticles provoke immune response against tumors but avoid side effects
In a new study, immunostimulatory drugs slowed tumor growth without producing systemic inflammation.
Why lung cancer doesn’t respond well to immunotherapy
A new study reveals that lymph nodes near the lungs create an environment that weakens T-cell responses to tumors.
A stealthy way to combat tumors
MIT biologists show that helper immune cells disguised as cancer cells can help rejuvenate T cells that attack tumors.
Differences in T cells’ functional states determine resistance to cancer therapy
Researchers decipher when and why immune cells fail to respond to immunotherapy, and suggest that T cells need a different kind of prodding in order to re-engage the immune response.
Chemical engineering meets cancer immunotherapy
Sachin Bhagchandani wins NCI Predoctoral to Postdoctoral Fellow Transition (F99/K00) Award.
School of Science welcomes new faculty members
This fall brings 14 new professors in the departments of Biology, Chemistry, Mathematics, and Physics.
Department of Biology welcomes three new faculty members
Recent additions bring diverse expertise and cultural perspectives to research community.